Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05832437 · ClinicalTrials.gov registry record · NA
BREATHE-Peds Pilot- II III Trial and Post Trial
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT05832437 is a NA study that has completed, run by Columbia University. The registered enrollment target is 67 participants.
The verdict
NCT05832437, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The overall aims of this study are to develop and pilot test BRief intervention to Evaluate Asthma THErapy (BREATHE)-Peds, a dyadic shared decision-making intervention, to improve asthma by supporting self-management among racial and ethnic minority early adolescents receiving care for uncontrolled asthma in federally-qualified health centers (FQHCs) in urban communities. Aim 1 (Phase I) involves developing the intervention through focus groups with early adolescents and caregivers. Aims 2 and 3 (Phase II) involve preliminary testing of the intervention through a pilot randomized controlled trial. This record is for Phase II and III only
Interventions
- BEHAVIORAL Control Intervention
- BEHAVIORAL BREATHE-Peds Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2024-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05832437
The ClinicalTrials.gov registry entry for NCT05832437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Intervention is the first listed.
NCT05832437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05832437 about?
NCT05832437 is a clinical study titled "BREATHE-Peds Pilot- II III Trial and Post Trial". The overall aims of this study are to develop and pilot test BRief intervention to Evaluate Asthma THErapy (BREATHE)-Peds, a dyadic shared decision-making intervention, to improve asthma by supporting self-management among racial and ethnic minority early adolescents receiving care for uncontrolled ...
What is the current status of trial NCT05832437?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2023-05-04. Estimated completion is 2024-12-13.
What interventions are being tested in trial NCT05832437?
The interventions under investigation include: Control Intervention (BEHAVIORAL), BREATHE-Peds Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05832437?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.